Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice

David M. Alvarado; Juhee Son; Larissa B. Thackray; Maria Florencia Gomez Castro; Sarada Prasad; Xueyang Cui; Naomi M. Sonnek; Michael Diamond; Siyuan Ding; Matthew A. Ciorba

doi:10.1093/ibd/izab274

Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice

David M. Alvarado, Juhee Son, Larissa B. Thackray, Maria Florencia Gomez Castro, Sarada Prasad, Xueyang Cui, Naomi M. Sonnek, Michael Diamond, Siyuan Ding, Matthew A. Ciorba

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	318-321
Number of pages	4
Journal	Inflammatory bowel diseases
Volume	28
Issue number	2
DOIs	https://doi.org/10.1093/ibd/izab274
State	Published - Feb 1 2022

Keywords

5-ASA
COVID-19
Crohn's disease
intestine
mucosal immunology

Access to Document

10.1093/ibd/izab274

Cite this

@article{d3989da738e445d99d20abe21f289a21,

title = "Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice",

keywords = "5-ASA, COVID-19, Crohn's disease, intestine, mucosal immunology",

author = "Alvarado, {David M.} and Juhee Son and Thackray, {Larissa B.} and {Gomez Castro}, {Maria Florencia} and Sarada Prasad and Xueyang Cui and Sonnek, {Naomi M.} and Michael Diamond and Siyuan Ding and Ciorba, {Matthew A.}",

year = "2022",

month = feb,

day = "1",

doi = "10.1093/ibd/izab274",

language = "English",

volume = "28",

pages = "318--321",

journal = "Inflammatory bowel diseases",

issn = "1078-0998",

number = "2",

}

TY - JOUR

T1 - Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice

AU - Alvarado, David M.

AU - Son, Juhee

AU - Thackray, Larissa B.

AU - Gomez Castro, Maria Florencia

AU - Prasad, Sarada

AU - Cui, Xueyang

AU - Sonnek, Naomi M.

AU - Diamond, Michael

AU - Ding, Siyuan

AU - Ciorba, Matthew A.

PY - 2022/2/1

Y1 - 2022/2/1

KW - 5-ASA

KW - COVID-19

KW - Crohn's disease

KW - intestine

KW - mucosal immunology

UR - http://www.scopus.com/inward/record.url?scp=85123968452&partnerID=8YFLogxK

U2 - 10.1093/ibd/izab274

DO - 10.1093/ibd/izab274

M3 - Article

C2 - 34849936

AN - SCOPUS:85123968452

SN - 1078-0998

VL - 28

SP - 318

EP - 321

JO - Inflammatory bowel diseases

JF - Inflammatory bowel diseases

IS - 2

ER -

Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice

Keywords

Access to Document

Other files and links

Cite this